Biotech 89bio overcomes regulatory hold up

摘要

Biotech 89bio shares jumped 30% in its Nasdaq debut on Monday after nearly a week long delay in pricing its IPO. 89bio priced an upsized offering of 5.3m shares at the US$16.00 ahead of Monday's opening bell to raise US$85m. The stock opened at US$20.00, up 25% from the offer price, before finishing at US$20.80, up 30%, on light volume.